12 results
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... or colonizing syndromes ... #pharmacology # ... dosing #medications ... #IDSA #Guidelines
LOW MOLECULAR WEIGHT HEPARIN (LMWH) DOSING RECOMMENDATIONS (Enoxaparin and Dalteparin):
 - VTE PROPHYLAXIS
 - VTE TREATMENT
HEPARIN (LMWH) DOSING ... PROPHYLAXIS - VTE TREATMENT ... ACUTE CORONARY SYNDROME ... THERAPY #LMWH #Dosing ... #Prophylaxis #Pharmacology
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... MDRTB #management #Treatment ... antimicrobials #pharmacology ... #dosing #idsa #
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
Managing warfarin INR ... results of the INR ... management #algorithm #pharmacology ... #treatment #medications ... hematology #warfarin #dosing
Warfarin - INR Goals, Initial Dosing and Bridging

Mechanical Mitral Valve Replacement 2.5-3.5 
Other Valve Replacement 2-3
, Initial Dosing ... Replacement 2-3 VTE Treatment ... appropriate warfarin dosing ... VTE treatment), ... Bridging #Initiation #Pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Refer to product label ... for effective treatment ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... MDRTB #management #Treatment ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
& Dry) is the treatment ... then be excreted using ... acute coronary syndrome ... & Dry” is the treatment ... icu #clinical #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Sjogren's Syndrome ... SLE • Mikulicz syndrome ... Membranoproliferative GN ... Adenocarcinoma Treatment ... lubricants • Pharmacologic
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... below for TB drug dosing ... Guidelines for dosing ... Tuberculosis #TB #IDSA ... infections #HIVAIDS #pharmacology